410 related articles for article (PubMed ID: 15173180)
1. Direct binding of Fas-associated death domain (FADD) to the tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 is regulated by the death effector domain of FADD.
Thomas LR; Henson A; Reed JC; Salsbury FR; Thorburn A
J Biol Chem; 2004 Jul; 279(31):32780-5. PubMed ID: 15173180
[TBL] [Abstract][Full Text] [Related]
2. The C-terminal tails of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas receptors have opposing functions in Fas-associated death domain (FADD) recruitment and can regulate agonist-specific mechanisms of receptor activation.
Thomas LR; Johnson RL; Reed JC; Thorburn A
J Biol Chem; 2004 Dec; 279(50):52479-86. PubMed ID: 15452120
[TBL] [Abstract][Full Text] [Related]
3. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis.
Harper N; Hughes M; MacFarlane M; Cohen GM
J Biol Chem; 2003 Jul; 278(28):25534-41. PubMed ID: 12721308
[TBL] [Abstract][Full Text] [Related]
4. Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5.
Jin TG; Kurakin A; Benhaga N; Abe K; Mohseni M; Sandra F; Song K; Kay BK; Khosravi-Far R
J Biol Chem; 2004 Dec; 279(53):55594-601. PubMed ID: 15485835
[TBL] [Abstract][Full Text] [Related]
5. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.
Kischkel FC; Lawrence DA; Chuntharapai A; Schow P; Kim KJ; Ashkenazi A
Immunity; 2000 Jun; 12(6):611-20. PubMed ID: 10894161
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Fas-associated death domain interactions by the death effector domain identified by a modified reverse two-hybrid screen.
Thomas LR; Stillman DJ; Thorburn A
J Biol Chem; 2002 Sep; 277(37):34343-8. PubMed ID: 12107169
[TBL] [Abstract][Full Text] [Related]
7. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
Suliman A; Lam A; Datta R; Srivastava RK
Oncogene; 2001 Apr; 20(17):2122-33. PubMed ID: 11360196
[TBL] [Abstract][Full Text] [Related]
8. FADD is required for DR4- and DR5-mediated apoptosis: lack of trail-induced apoptosis in FADD-deficient mouse embryonic fibroblasts.
Kuang AA; Diehl GE; Zhang J; Winoto A
J Biol Chem; 2000 Aug; 275(33):25065-8. PubMed ID: 10862756
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD).
Wajant H; Haas E; Schwenzer R; Muhlenbeck F; Kreuz S; Schubert G; Grell M; Smith C; Scheurich P
J Biol Chem; 2000 Aug; 275(32):24357-66. PubMed ID: 10823821
[TBL] [Abstract][Full Text] [Related]
10. Fas- and tumor necrosis factor-mediated apoptosis uses the same binding surface of FADD to trigger signal transduction. A typical model for convergent signal transduction.
Bang S; Jeong EJ; Kim IK; Jung YK; Kim KS
J Biol Chem; 2000 Nov; 275(46):36217-22. PubMed ID: 10952991
[TBL] [Abstract][Full Text] [Related]
11. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
Song JH; Bellail A; Tse MC; Yong VW; Hao C
J Neurosci; 2006 Mar; 26(12):3299-308. PubMed ID: 16554480
[TBL] [Abstract][Full Text] [Related]
12. Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway.
Siegmund D; Mauri D; Peters N; Juo P; Thome M; Reichwein M; Blenis J; Scheurich P; Tschopp J; Wajant H
J Biol Chem; 2001 Aug; 276(35):32585-90. PubMed ID: 11384965
[TBL] [Abstract][Full Text] [Related]
13. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB.
Schneider P; Thome M; Burns K; Bodmer JL; Hofmann K; Kataoka T; Holler N; Tschopp J
Immunity; 1997 Dec; 7(6):831-6. PubMed ID: 9430228
[TBL] [Abstract][Full Text] [Related]
14. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
Mitsiades N; Poulaki V; Mitsiades C; Tsokos M
Cancer Res; 2001 Mar; 61(6):2704-12. PubMed ID: 11289151
[TBL] [Abstract][Full Text] [Related]
15. Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8.
Sprick MR; Rieser E; Stahl H; Grosse-Wilde A; Weigand MA; Walczak H
EMBO J; 2002 Sep; 21(17):4520-30. PubMed ID: 12198154
[TBL] [Abstract][Full Text] [Related]
16. TRAIL receptor and CD95 signal to mitochondria via FADD, caspase-8/10, Bid, and Bax but differentially regulate events downstream from truncated Bid.
Werner AB; de Vries E; Tait SW; Bontjer I; Borst J
J Biol Chem; 2002 Oct; 277(43):40760-7. PubMed ID: 12196516
[TBL] [Abstract][Full Text] [Related]
17. Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction.
Wajant H; Johannes FJ; Haas E; Siemienski K; Schwenzer R; Schubert G; Weiss T; Grell M; Scheurich P
Curr Biol; 1998 Jan; 8(2):113-6. PubMed ID: 9427646
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling.
Harper N; Hughes MA; Farrow SN; Cohen GM; MacFarlane M
J Biol Chem; 2003 Nov; 278(45):44338-47. PubMed ID: 12920112
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of DEDD2, a death effector domain-containing protein.
Roth W; Stenner-Liewen F; Pawlowski K; Godzik A; Reed JC
J Biol Chem; 2002 Mar; 277(9):7501-8. PubMed ID: 11741985
[TBL] [Abstract][Full Text] [Related]
20. A novel family of viral death effector domain-containing molecules that inhibit both CD-95- and tumor necrosis factor receptor-1-induced apoptosis.
Hu S; Vincenz C; Buller M; Dixit VM
J Biol Chem; 1997 Apr; 272(15):9621-4. PubMed ID: 9092488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
